|
參考文獻 1.Ma C-M, Ding M, Li JS, Lee MC, Pawlicki T, Deng J. A comparative dosimetric study on tangential photon beams, intensity-modulated radiation therapy (IMRT) and modulated electron radiotherapy (MERT) for breast cancer treatment. Physics in Medicine & Biology. 2003;48(7):909. 2.Mayo CS, Urie MM, Fitzgerald TJ. Hybrid IMRT plans—concurrently treating conventional and IMRT beams for improved breast irradiation and reduced planning time. International Journal of Radiation Oncology* Biology* Physics. 2005;61(3):922-32. 3.Sun LM, Huang EY, Liang JA, Meng FY, Chang GH, Tsao MJ. Evaluation the consistency of location of moist desquamation and skin high dose area for breast cancer patients receiving adjuvant radiotherapy after breast conservative surgery. Radiation Oncology. 2013;8:50. 4.Farhood B, Mahdavi SR, Emranpour MH, Mohammadi Asl K, Nekoui N, Knaup C. Skin reaction in radiation therapy for breast cancer. Iranian Journal of Medical Physics. 2014;11(4):316-21. 5.Kraus-Tiefenbacher U, Sfintizky A, Welzel G, Simeonova A, Sperk E, Siebenlist K, et al. Factors of influence on acute skin toxicity of breast cancer patients treated with standard three-dimensional conformal radiotherapy (3D-CRT) after breast conserving surgery (BCS). Radiation Oncology. 2012;7:217. 6.Cox JD, Ang KK. Radiation Oncology E-Book: Rationale, Technique, Results: Elsevier Health Sciences; 2009. 7.Dawson LA, Normolle D, Balter JM, McGinn CJ, Lawrence TS, Ten Haken RK. Analysis of radiation-induced liver disease using the Lyman NTCP model. International Journal of Radiation Oncology* Biology* Physics. 2002;53(4):810-21. 8.Bentzen SM, Constine LS, Deasy JO, Eisbruch A, Jackson A, Marks LB, et al. Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. International Journal of Radiation Oncology* Biology* Physics. 2010;76(3 Suppl):S3-S9. 9.Ryan JL. Ionizing radiation: the good, the bad, and the ugly. Journal of Investigative Dermatology. 2012;132(3):985-93. 10.Halperin EC, Brady LW, Perez CA, Wazer DE. Perez & Brady's principles and practice of radiation oncology: Lippincott Williams & Wilkins; 2013. 11.Washington CM, Leaver DT. Principles and practice of radiation therapy: Elsevier Health Sciences; 2015. 12.Barkham AM. Radiotherapy skin reactions and treatments. Prof Nurse. 1993;8(11):732-6. 13.Chen MF, Chen WC, Lai CH, Hung CH, Liu KC, Cheng YH. Predictive factors of radiation-induced skin toxicity in breast cancer patients. BMC Cancer. 2010;10:508. 14.Lo Y-C, Yasuda G, Fitzgerald TJ, Urie MM. Intensity modulation for breast treatment using static multi-leaf collimators. International Journal of Radiation Oncology* Biology* Physics. 2000;46(1):187-94. 15.Donovan EM, Johnson U, Shentall G, Evans PM, Neal AJ, Yarnold JR. Evaluation of compensation in breast radiotherapy: a planning study using multiple static fields. International Journal of Radiation Oncology* Biology* Physics. 2000;46(3):671-9. 16.Meier R, Hatton J, Mehta V. Forward-planning breast IMRT: Early clinical experience. International Journal of Radiation Oncology* Biology* Physics. 2003;57(2):S369. 17.Harsolia A, Kestin L, Grills I, Wallace M, Jolly S, Jones C, et al. Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy. International Journal of Radiation Oncology* Biology* Physics. 2007;68(5):1375-80. 18.Coles C, Moody A, Wilson C, Burnet N. Reduction of radiotherapy-induced late complications in early breast cancer: the role of intensity-modulated radiation therapy and partial breast irradiation: part II—radiotherapy strategies to reduce radiation-induced late effects. Clinical oncology. 2005;17(2):98-110. 19.Chin L, Cheng C, Siddon R, Rice R, Mijnheer B, Harris J. Three-dimensional photon dose distributions with and without lung corrections for tangential breast intact treatments. International Journal of Radiation Oncology* Biology* Physics. 1989;17(6):1327-35. 20.Jalali R, Malde R, Bhutani R, Budrukkar A, Badwe R, Sarin R. Prospective evaluation of concomitant tumour bed boost with whole breast irradiation in patients with locally advanced breast cancer undergoing breast-conserving therapy. The Breast. 2008;17(1):64-70. 21.Robertson JM, Söhn M, Yan D. Predicting grade 3 acute diarrhea during radiation therapy for rectal cancer using a cutoff-dose logistic regression normal tissue complication probability model. International Journal of Radiation Oncology* Biology* Physics. 2010;77(1):66-72. 22.Beetz I, Schilstra C, van der Schaaf A, van den Heuvel ER, Doornaert P, van Luijk P, et al. NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors. Radiotherapy and Oncology. 2012;105(1):101-6. 23.Seppenwoolde Y, Lebesque JV, De Jaeger K, Belderbos JS, Boersma LJ, Schilstra C, et al. Comparing different NTCP models that predict the incidence of radiation pneumonitis. International Journal of Radiation Oncology* Biology* Physics. 2003;55(3):724-35. 24.Blanchet FG, Legendre P, Borcard D. Forward selection of explanatory variables. Ecology. 2008;89(9):2623-32. 25.Xu C-J, van der Schaaf A, Van't Veld AA, Langendijk JA, Schilstra C. Statistical validation of normal tissue complication probability models. International Journal of Radiation Oncology* Biology* Physics. 2012;84(1):e123-e9. 26.Farace P, Zucca S, Solla I, Fadda G, Durzu S, Porru S, et al. Planning hybrid intensity modulated radiation therapy for whole-breast irradiation. International Journal of Radiation Oncology* Biology* Physics. 2012;84(1):e115-e22. 27.Freedman GM, Li T, Nicolaou N, Chen Y, Ma CC-M, Anderson PR. Breast intensity-modulated radiation therapy reduces time spent with acute dermatitis for women of all breast sizes during radiation. International Journal of Radiation Oncology* Biology* Physics. 2009;74(3):689-94. 28.Abo-Madyan Y, Aziz MH, Aly MM, Schneider F, Sperk E, Clausen S, et al. Second cancer risk after 3D-CRT, IMRT and VMAT for breast cancer. Radiotherapy and Oncology. 2014;110(3):471-6. 29.Nicolini G, Clivio A, Fogliata A, Vanetti E, Cozzi L. Simultaneous integrated boost radiotherapy for bilateral breast: a treatment planning and dosimetric comparison for volumetric modulated arc and fixed field intensity modulated therapy. Radiation Oncology. 2009;4(1):1-12. 30.Mansouri S, Naim A, Glaria L, Marsiglia H. Dosimetric evaluation of 3-D conformal and intensity-modulated radiotherapy for breast cancer after conservative surgery. Asian Pacific Journal Cancer Prevention. 2014;15(11):4727-32. 31.Michalski A, Atyeo J, Cox J, Rinks M, Morgia M, Lamoury G. A dosimetric comparison of 3D-CRT, IMRT, and static tomotherapy with an SIB for large and small breast volumes. Medical Dosimetry. 2014;39(2):163-8. 32.Taylor A, Powell M. Intensity-modulated radiotherapy—what is it? Cancer Imaging. 2004;4(2):68. 33.Tsai PF, Lin SM, Lee SH, Yeh CY, Huang YT, Lee CC, et al. The feasibility study of using multiple partial volumetric-modulated arcs therapy in early stage left-sided breast cancer patients. Journal of Applied Clinical Medical Physics. 2012;13(5):3806. 34.Bedford JL, Warrington AP. Commissioning of volumetric modulated arc therapy (VMAT). Int J Radiat Oncol Biol Phys. 2009;73(2):537-45. 35.Lee TF, Ting HM, Chao PJ, Fang FM. Dual arc volumetric-modulated arc radiotherapy (VMAT) of nasopharyngeal carcinomas: a simultaneous integrated boost treatment plan comparison with intensity-modulated radiotherapies and single arc VMAT. Clinical Oncololy (R Coll Radiol). 2012;24(3):196-207. 36.Boomsma MJ, Bijl HP, Christianen ME, Beetz I, Chouvalova O, Steenbakkers RJ, et al. A prospective cohort study on radiation-induced hypothyroidism: development of an NTCP model. International Journal of Radiation Oncology* Biology* Physics. 2012;84(3):e351-e6. 37.Dawson LA, Normolle D, Balter JM, McGinn CJ, Lawrence TS, Ten Haken RK. Analysis of radiation-induced liver disease using the Lyman NTCP model. International Journal of Radiation Oncology* Biology* Physics. 2002;53(4):810-21. 38.Semenenko V, Li X. Lyman–Kutcher–Burman NTCP model parameters for radiation pneumonitis and xerostomia based on combined analysis of published clinical data. Physics in Medicine & Biology. 2008;53(3):737. 39.Lee T-F, Chao P-J, Ting H-M, Chang L, Huang Y-J, Wu J-M, et al. Using multivariate regression model with least absolute shrinkage and selection operator (LASSO) to predict the incidence of xerostomia after intensity-modulated radiotherapy for head and neck cancer. PloS one. 2014;9(2):e89700. 40.Lee T-F, Yeh S-A, Chao P-J, Chang L, Chiu C-L, Ting H-M, et al. Normal tissue complication probability modeling for cochlea constraints to avoid causing tinnitus after head-and-neck intensity-modulated radiation therapy. Radiation Oncology. 2015;10(1):194. 41.Lee T-F, Fang F-M. Quantitative analysis of normal tissue effects in the clinic (QUANTEC) guideline validation using quality of life questionnaire datasets for parotid gland constraints to avoid causing xerostomia during head-and-neck radiotherapy. Radiotherapy and Oncology. 2013;106(3):352-8. 42.Lee T-F, Liou M-H, Ting H-M, Chang L, Lee H-Y, Leung SW, et al. Patient-and therapy-related factors associated with the incidence of xerostomia in nasopharyngeal carcinoma patients receiving parotid-sparing helical tomotherapy. Scientific reports. 2015;5:13165. 43.Kong C, Zhu X-z, Lee T-F, Feng P-b, Xu J-h, Qian P-d, et al. LASSO-based NTCP model for radiation-induced temporal lobe injury developing after intensity-modulated radiotherapy of nasopharyngeal carcinoma. Scientific reports. 2016;6:26378. 44.Lee T-F, Liou M-H, Huang Y-J, Chao P-J, Ting H-M, Lee H-Y, et al. LASSO NTCP predictors for the incidence of xerostomia in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma. Scientific reports. 2014;4:6217. 45.Moons KG, Kengne AP, Grobbee DE, Royston P, Vergouwe Y, Altman DG, et al. Risk prediction models: II. External validation, model updating, and impact assessment. Heart. 2012;98(9):691-8. 46.Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148(3):839-43. 47.Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143(1):29-36. 48.Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41-55. 49.Zhao P, Su X, Ge T, Fan J. Propensity score and proximity matching using random forest. Contemporary clinical trials. 2016;47:85-92. 50.Austin PC. The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments. Statistics in Medicine. 2014;33(7):1242-58. 51.Gayat E, Pirracchio R, Resche-Rigon M, Mebazaa A, Mary JY, Porcher R. Propensity scores in intensive care and anaesthesiology literature: a systematic review. Intensive Care Med. 2010;36(12):1993-2003. 52.Pham T, Combes A, Roze H, Chevret S, Mercat A, Roch A, et al. Extracorporeal membrane oxygenation for pandemic influenza A(H1N1)-induced acute respiratory distress syndrome: a cohort study and propensity-matched analysis. American Journal of Respiratory and Critical Care Medicine. 2013;187(3):276-85. 53.RNaM S. Bayesian Networks in {R} with Applications in Systems Biology. Springer, Berlin; 2013. 54.Jordan MI. Learning in graphical models: Springer Science & Business Media; 1998. 55.Stich T. Bayesian networks and structure learning: Diploma Thesis, Computer Science and Engineering, University of Mannheim ; 2004. 56.Gadewadikar J, Kuljaca O, Agyepong K, Sarigul E, Zheng Y, Zhang P. Exploring Bayesian networks for medical decision support in breast cancer detection. African Journal of Mathematics and Computer Science Research. 2010;3(10):225-31. 57.Carsel RF, Parrish RS. Developing joint probability distributions of soil water retention characteristics. Water resources research. 1988;24(5):755-69. 58.Lee S, Ybarra N, Jeyaseelan K, Faria S, Kopek N, Brisebois P, et al. Bayesian network ensemble as a multivariate strategy to predict radiation pneumonitis risk. Medical physics. 2015;42(5):2421-30. 59.Recht A, Edge SB, Solin LJ, Robinson DS, Estabrook A, Fine RE, et al. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. Journal of clinical oncology. 2001;19(5):1539-69. 60.Wang Q, Jie W, Liang Z, Wu H, Cheng J. Postmastectomy intensity modulation radiated therapy of chest wall and regional nodes: Retrospective analysis of the performance and complications up for 5 years. Medicine. 2017;96(39). 61.Jung K, Sabri S, Hanson J, Xu Y, Wang YW, Lai R, et al. Elevated ARG1 expression in primary monocytes-derived macrophages as a predictor of radiation-induced acute skin toxicities in early breast cancer patients. Cancer biology & therapy. 2015;16(9):1281-8. 62.Lee JH, Kay CS, Maeng LS, Oh SJ, Lee AH, Lee JD, et al. The clinical features and pathophysiology of acute radiation dermatitis in patients receiving tomotherapy. Annals of dermatology. 2009;21(4):358-63. 63.Harper JL, Franklin LE, Jenrette JM, Aguero EG. Skin toxicity during breast irradiation: pathophysiology and management. Southern Medical Journal. 2004;97(10):989-94. 64.Freedman GM, Anderson PR, Li J, Eisenberg DF, Hanlon AL, Wang L, et al. Intensity modulated radiation therapy (IMRT) decreases acute skin toxicity for women receiving radiation for breast cancer. American Journal of Clinical Oncology. 2006;29(1):66-70. 65.Pignol J-P, Olivotto I, Rakovitch E, Gardner S, Sixel K, Beckham W, et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. Journal of Clinical Oncology. 2008;26(13):2085-92. 66.Chung H, Jin H, Dempsey JF, Liu C, Palta J, Suh TS, et al. Evaluation of surface and build‐up region dose for intensity‐modulated radiation therapy in head and neck cancer. Medical physics. 2005;32(8):2682-9. 67.Trott K-R, Doerr W, Facoetti A, Hopewell J, Langendijk J, van Luijk P, et al. Biological mechanisms of normal tissue damage: importance for the design of NTCP models. Radiotherapy and Oncology. 2012;105(1):79-85. 68.Vicini FA, Sharpe M, Kestin L, Martinez A, Mitchell CK, Wallace MF, et al. Optimizing breast cancer treatment efficacy with intensity-modulated radiotherapy. International Journal of Radiation Oncology* Biology* Physics. 2002;54(5):1336-44. 69.Group IMRTCW. Intensity-modulated radiotherapy: current status and issues of interest. International Journal of Radiation Oncology* Biology* Physics. 2001;51(4):880-914. 70.Hong L, Hunt M, Chui C, Spirou S, Forster K, Lee H, et al. Intensity-modulated tangential beam irradiation of the intact breast. International Journal of Radiation Oncology* Biology* Physics. 1999;44(5):1155-64. 71.Hurkmans CW, Cho BJ, Damen E, Zijp L, Mijnheer BJ. Reduction of cardiac and lung complication probabilities after breast irradiation using conformal radiotherapy with or without intensity modulation. Radiotherapy and oncology. 2002;62(2):163-71. 72.Freedman GM, Anderson PR, Li J, Eisenberg DF, Hanlon AL, Wang L, et al. Intensity modulated radiation therapy (IMRT) decreases acute skin toxicity for women receiving radiation for breast cancer. American journal of clinical oncology. 2006;29(1):66-70. 73.Harsolia A, Kestin L, Grills I, Wallace M, Jolly S, Jones C, et al. Intensity-modulated radiotherapy results in significant decrease in clinical toxicities compared with conventional wedge-based breast radiotherapy. International Journal of Radiation Oncology* Biology* Physics.. 2007;68(5):1375-80. 74.Pignol JP, Olivotto I, Rakovitch E, Gardner S, Sixel K, Beckham W, et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. Journal of Clinical Oncology. 2008;26(13):2085-92. 75.Rose MA, Olivotto I, Cady B, Koufman C, Osteen R, Silver B, et al. Conservative surgery and radiation therapy for early breast cancer: long-term cosmetic results. Archives of surgery. 1989;124(2):153-7. 76.BENTZEN SM, OVERGAARD M. Clinical radiobiology and normal-tissue morbidity after breast cancer treatment. Advances in radiation biology. 18: Elsevier; 1994. p. 25-51. 77.Kramer JD. Essentials of Gerontological Nursing: Adaptation to the Aging Process. Journal of Gerontological Nursing. 1996;22(7):43-4. 78.Fisher ER, Sass R, Fisher B, Gregorio R, Brown R, Wickerham L, et al. Pathologic findings from the national surgical adjuvant breast project (protocol 6). Relation of local breast recurrence to multicentricity. Cancer. 1986;57(9):1717-24. 79.Hälg RA, Besserer J, Schneider U. Systematic measurements of whole‐body dose distributions for various treatment machines and delivery techniques in radiation therapy. Medical physics. 2012;39(12):7662-76. 80.Van Limbergen E, Briot E, Drijkoningen M. The source-skin distance measuring bridge: a method to avoid radiation teleangiectasia in the skin after interstitial therapy for breast cancer. International Journal of Radiation Oncology* Biology* Physics. 1990;18(5):1239-44. 81.Qiu J-J, Chang Z, Wu QJ, Yoo S, Horton J, Yin F-F. Impact of volumetric modulated arc therapy technique on treatment with partial breast irradiation. International Journal of Radiation Oncology* Biology* Physics. 2010;78(1):288-96. 82.Popescu CC, Olivotto IA, Beckham WA, Ansbacher W, Zavgorodni S, Shaffer R, et al. Volumetric modulated arc therapy improves dosimetry and reduces treatment time compared to conventional intensity-modulated radiotherapy for locoregional radiotherapy of left-sided breast cancer and internal mammary nodes. International Journal of Radiation Oncology* Biology* Physics. 2010;76(1):287-95. 83.Johansen S, Cozzi L, Olsen DR. A planning comparison of dose patterns in organs at risk and predicted risk for radiation induced malignancy in the contralateral breast following radiation therapy of primary breast using conventional, IMRT and volumetric modulated arc treatment techniques. Acta Oncologica. 2009;48(4):495-503. 84.Kaviani A, Sodagari N, Sheikhbahaei S, Eslami V, Hafezi-Nejad N, Safavi A, et al. From radical mastectomy to breast-conserving therapy and oncoplastic breast surgery: a narrative review comparing oncological result, cosmetic outcome, quality of life, and health economy. ISRN oncology. 2013;2013. 85.Liu M, Moiseenko V, Agranovich A, Karvat A, Kwan W, Saleh ZH, et al. Normal tissue complication probability (NTCP) modeling of late rectal bleeding following external beam radiotherapy for prostate cancer: a test of the QUANTEC-recommended NTCP model. Acta Oncologica. 2010;49(7):1040-4. 86.Warkentin B, Stavrev P, Stavreva N, Field C, Fallone BG. A TCP‐NTCP estimation module using DVHs and known radiobiological models and parameter sets. Journal of Applied Clinical Medical Physics. 2004;5(1):50-63. 87.Leunens G, Verstraete J, Dutreix A, Van der Schueren E. Assessment of dose inhomogeneity at target level by in vivo dosimetry: can the recommended 5% accuracy in the dose delivered to the target volume be fulfilled in daily practice? Radiotherapy and Oncology. 1992;25(4):242-50. 88.Luxton G, Keall PJ, King CR. A new formula for normal tissue complication probability (NTCP) as a function of equivalent uniform dose (EUD). Physics in Medicine & Biology. 2007;53(1):23. 89.Landry JC, Yang GY, Ting JY, Staley CA, Torres W, Esiashvili N, et al. Treatment of pancreatic cancer tumors with intensity-modulated radiation therapy (IMRT) using the volume at risk approach (VARA): employing dose-volume histogram (DVH) and normal tissue complication probability (NTCP) to evaluate small bowel toxicity. Medical Dosimetry. 2002;27(2):121-9. 90.Widesott L, Pierelli A, Fiorino C, Dell'Oca I, Broggi S, Cattaneo GM, et al. Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: planning comparison and NTCP evaluation. International Journal of Radiation Oncology* Biology* Physics. 2008;72(2):589-96. 91.Sussman C, Bates-Jensen BM. Wound care: a collaborative practice manual: Lippincott Williams & Wilkins; 2007. 92.Tejwani A, Wu S, Jia Y, Agulnik M, Millender L, Lacouture ME. Increased risk of high‐grade dermatologic toxicities with radiation plus epidermal growth factor receptor inhibitor therapy. Cancer. 2009;115(6):1286-99. 93.Sharp L, Johansson H, Hatschek T, Bergenmar M. Smoking as an independent risk factor for severe skin reactions due to adjuvant radiotherapy for breast cancer. The Breast. 2013;22(5):634-8. 94.Cohen IK, Die-gelmann RF, Lindblad WJ, Hugo NE. Wound healing: biochemical and clinical aspects. Plastic and Reconstructive Surgery. 1992;90(5):926. 95.Cole E. Wound management in the A&E department. Nursing Standard. 2003;17(46):45-55. 96.Des Rochers C, Dische S, Saunders M. The problem of cigarette smoking in radiotherapy for cancer in the head and neck. Clinical Oncology. 1992;4(4):214-6. 97.Bentzen SM, Overgaard J, editors. Patient-to-patient variability in the expression of radiation-induced normal tissue injury. Seminars in radiation oncology; 1994: Elsevier. 98.Austin PC. A Tutorial and Case Study in Propensity Score Analysis: An Application to Estimating the Effect of In-Hospital Smoking Cessation Counseling on Mortality. Multivariate Behav Res. 2011;46(1):119-51. 99.Scott-Brown M, Miah A, Harrington K, Nutting C. Evidence-based review: quality of life following head and neck intensity-modulated radiotherapy. Radiotherapy and Oncology. 2010;97(2):249-57. 100.Beetz I, Schilstra C, Burlage FR, Koken PW, Doornaert P, Bijl HP, et al. Development of NTCP models for head and neck cancer patients treated with three-dimensional conformal radiotherapy for xerostomia and sticky saliva: the role of dosimetric and clinical factors. Radiotherapy and Oncology. 2012;105(1):86-93. 101.Lee N, Chuang C, Quivey JM, Phillips TL, Akazawa P, Verhey LJ, et al. Skin toxicity due to intensity-modulated radiotherapy for head-and-neck carcinoma. International Journal of Radiation Oncology* Biology* Physics. 2002;53(3):630-7. 102.Kelly A, Hardcastle N, Metcalfe P, Cutajar D, Quinn A, Foo K, et al. Surface dosimetry for breast radiotherapy in the presence of immobilization cast material. Physics in Medicine & Biology. 2011;56(4):1001. 103.Kry SF, Smith SA, Weathers R, Stovall M. Skin dose during radiotherapy: a summary and general estimation technique. Journal of applied clinical medical physics. 2012;13(3):20-34.
|